Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Opinion in Supportive and Palliative Care|November 6, 2013
Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancerJames T Dalton, Ryan P Taylor, Michael L Mohler, et al.
Medicinal Research Reviews|October 16, 2008
Recent and emerging anti-diabetes targetsMichael L Mohler, Yali He, Zhongzhi Wu, et al.
Expert Opinion on Therapeutic Patents|February 11, 2010
Dissociated non-steroidal glucocorticoids: tuning out untoward effectsMichael L Mohler, Yali He, Zhongzhi Wu, et al.
Expert Opinion on Therapeutic Patents|February 11, 2010
Non-steroidal glucocorticoid receptor antagonists: the race to replace RU-486 for anti-glucocorticoid therapyMichael L Mohler, Yali He, Zhongzhi Wu, et al.
Nuclear Receptor Signaling|December 17, 2008
Selective androgen receptor modulators in preclinical and clinical developmentRamesh Narayanan, Michael L Mohler, Casey E Bohl, et al.
Tetrahedron Letters|December 15, 2007
Synthesis of oxazolidinedione derived bicalutamide analogsVipin A Nair, Suni M Mustafa, Michael L Mohler, et al.
Journal of Medicinal Chemistry|October 23, 2020
Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate CancerYali He, Dong-Jin Hwang, Suriyan Ponnusamy, et al.
International Journal of Molecular Sciences|March 6, 2021
An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate CancerMichael L Mohler, Arunima Sikdar, Suriyan Ponnusamy, et al.
Pageof 3